123 related articles for article (PubMed ID: 18625954)
1. Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.
Ohguro N; Hashida N; Tano Y
Arch Ophthalmol; 2008 Jul; 126(7):1002-3. PubMed ID: 18625954
[No Abstract] [Full Text] [Related]
2. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
3. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
[TBL] [Abstract][Full Text] [Related]
4. Successful long-term control of lymphomatous meningitis with intraventricular rituximab.
Birnbaum T; Baumgarten Lv; Dudel C; Straube A
J Clin Neurosci; 2014 Feb; 21(2):356-8. PubMed ID: 24054402
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
Hansen PB; Al-Farra G
Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
[TBL] [Abstract][Full Text] [Related]
6. Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab.
Maximiano Alonso C; Sánchez Ruiz AC; Cantos Sánchez de Ibargüen B; Méndez García M; Ronco IS; Provencio Pulla M
Clin Transl Oncol; 2010 Oct; 12(10):701-3. PubMed ID: 20947485
[TBL] [Abstract][Full Text] [Related]
7. Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
Go A; Venugopal P; Loew J; Djordjevic D
Clin Adv Hematol Oncol; 2006 Jun; 4(6):439-41. PubMed ID: 16981666
[No Abstract] [Full Text] [Related]
8. Rituximab for early-stage diffuse large-B-cell lymphoma.
Friedberg JW
Lancet Oncol; 2006 May; 7(5):357-9. PubMed ID: 16648037
[No Abstract] [Full Text] [Related]
9. Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma.
Ferrari A; Luppi M; Lazzerini A; Potenza L; Cavallini GM; Torelli G
Lancet Oncol; 2006 Mar; 7(3):274. PubMed ID: 16510339
[No Abstract] [Full Text] [Related]
10. Clinical review: treatment of vitreoretinal lymphoma.
Pe'er J; Hochberg FH; Foster CS
Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
[TBL] [Abstract][Full Text] [Related]
11. Intraocular rituximab.
Singh AD; Peereboom DM
Eye (Lond); 2007 Dec; 21(12):1453-4. PubMed ID: 18159211
[No Abstract] [Full Text] [Related]
12. Rituximab for intraocular lymphoma.
Itty S; Pulido JS
Retina; 2009 Feb; 29(2):129-32. PubMed ID: 19202422
[No Abstract] [Full Text] [Related]
13. Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma.
Riemens A; Missotten T; Baarsma S; Vidovic-Valentincic N; Novac-Andrejcic K; Erckens R; Kuijpers R; Lokhorst H; Rothova A
Acta Ophthalmol; 2014 Mar; 92(2):e159-60. PubMed ID: 23819861
[No Abstract] [Full Text] [Related]
14. Diagnostic criteria for primary ocular lymphoma.
Arcinue CA; Hochberg F; Neumann R; Foster CS
Ophthalmology; 2013 Mar; 120(3):646-646.e2. PubMed ID: 23714608
[No Abstract] [Full Text] [Related]
15. [Measurement of rituximab concentration in the cerebrospinal fluid in CNS lymphoma].
Kikuchi A; Kawada H; Iwaki Y; Machida S; Tsuchiya T; Fukuda R; Hotta T
Rinsho Ketsueki; 2004 Dec; 45(12):1255-7. PubMed ID: 15678918
[TBL] [Abstract][Full Text] [Related]
16. Intraocular use of rituximab.
Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
[TBL] [Abstract][Full Text] [Related]
17. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
18. Rituximab maintenance therapy in central nervous system lymphoma?
Murawski N; Pfreundschuh M
Leuk Lymphoma; 2009 Oct; 50(10):1555-6. PubMed ID: 19757314
[No Abstract] [Full Text] [Related]
19. Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?
Cheah CY; Seymour JF
Leuk Lymphoma; 2014 Mar; 55(3):471-3. PubMed ID: 23906017
[No Abstract] [Full Text] [Related]
20. Rituximab for bone lymphoma.
Savage DG; Staron R
Ann Intern Med; 2001 Jun; 134(12):1156-7. PubMed ID: 11412072
[No Abstract] [Full Text] [Related]
[Next] [New Search]